Actions

Medical weight loss nyc

From W8MD weight loss and sleep centers

Medical weight loss in NYC, GLP-1 injections, Wegovy pills, Foundayo, Contrave, diet pills, emerging obesity medications, and W8MD medical weight loss care


Medical weight loss NYC
W8MD-Team.jpg
W8MD Weight Loss, Sleep and MedSpa offers physician-supervised medical weight loss, GLP-1 medications, diet pills, sleep medicine, and long-term maintenance care.
Location Brooklyn, New York City
NYC office 2632 E. 21st Street, Suite L3, Brooklyn, NY 11235
Phone 718-946-5500
Core services Medical weight loss, GLP-1 weight loss injections, diet pills, nutrition, sleep apnea screening, home sleep study, maintenance
Medication examples Wegovy, Zepbound, Ozempic, Rybelsus, Foundayo, Contrave, Qsymia, Phentermine, Topiramate, Orlistat, Saxenda
Service areas Brooklyn, Manhattan, Queens, Staten Island, Long Island, New Jersey, Connecticut
W8MD medical weight loss NYC

Medical Weight Loss NYC

Medical weight loss NYC refers to physician-supervised treatment for obesity, overweight, insulin resistance, food noise, appetite regulation, sleep apnea, prediabetes, type 2 diabetes, and long-term chronic weight management for patients in New York City and nearby areas. Unlike short-term dieting, medical weight loss evaluates the underlying medical, hormonal, metabolic, nutritional, sleep, medication-related, and behavioral factors that make weight loss difficult.

At W8MD Weight Loss, Sleep and MedSpa, patients in Brooklyn, New York City, Manhattan, Queens, Staten Island, Long Island, New Jersey, and Connecticut can receive physician-supervised medical weight loss with over 20 years of experience. W8MD offers a broad range of FDA-approved and medically appropriate options, including diet pills, GLP-1 weight loss injections, Wegovy injection, Wegovy pill, Wegovy HD, Ozempic for weight loss education, Rybelsus, Zepbound for weight loss, Mounjaro for weight loss education, Contrave, Qsymia, Orlistat, Phentermine, Topiramate, Saxenda, Foundayo, meal replacement support, and long-term maintenance planning.

20+ years
W8MD experience in medical weight loss, obesity medicine, and sleep medicine.
All major options
Diet pills, GLP-1 injections, oral GLP-1 pills, and maintenance plans.
Affordable GLP-1
Semaglutide and tirzepatide-based options when medically appropriate and available.
NYC + nearby
Serving Brooklyn, NYC, New Jersey, Connecticut, and surrounding areas.

W8MD affordability highlight: W8MD offers semaglutide-based options starting as low as $29.99 per week and up with insurance for qualifying visits, or $59.99 per week and up for self-pay patients when medically appropriate and available. Tirzepatide-based options may start as low as $45.00 per week and up with insurance for qualifying visits, or $69.99 per week and up for self-pay patients when medically appropriate and available. Pricing, pharmacy availability, medication access, insurance coverage, and eligibility vary by patient and location.

W8MD patient benefit: W8MD helps patients choose among FDA-approved and medically appropriate options based on BMI, waist circumference, insulin resistance, diabetes status, blood pressure, sleep apnea risk, medication history, side effects, appetite pattern, food noise, injection versus pill preference, insurance coverage, affordability, and long-term maintenance goals.

Medical weight loss works best when medication is combined with nutrition, protein intake, sleep optimization, physical activity, and follow-up.
Before-and-after weight loss image. Individual results vary and require medical supervision.
Body mass index is one tool used to determine eligibility for obesity treatment and anti-obesity medications.

Overview

Medical weight loss in NYC is a physician-supervised approach to weight reduction and long-term weight maintenance. It may include nutrition, exercise counseling, sleep evaluation, behavior change, prescription medications, GLP-1 injections, oral GLP-1 pills, traditional diet pills, meal replacements, and ongoing maintenance.

Medical weight loss is appropriate because obesity is a chronic medical condition, not simply a short-term diet problem. Many patients need evaluation for underlying causes such as:

Why choose medical weight loss instead of dieting alone?

Short-term diets often fail because they do not address biology. After weight loss, hunger may increase, metabolism may adapt, food noise may return, sleep problems may persist, and weight regain may occur.

Medical weight loss can help by:

  • Identifying medical contributors to weight gain
  • Reducing appetite and cravings
  • Treating food noise
  • Improving insulin resistance
  • Evaluating sleep apnea
  • Preserving muscle during weight loss
  • Choosing medications safely
  • Managing medication side effects
  • Supporting long-term maintenance
  • Helping with insurance prior authorization when coverage is available

W8MD NYC medical weight loss office

W8MD Brooklyn / New York City Weight Loss Center

Address: 2632 E. 21st Street, Suite L3, Brooklyn, NY 11235

Phone: 718-946-5500

Appointment: Book Brooklyn / NYC appointment

The W8MD Brooklyn / NYC office serves patients from Brooklyn, Manhattan, Queens, Staten Island, Long Island, New Jersey, and Connecticut who are searching for medical weight loss, affordable GLP-1 injections, semaglutide, tirzepatide, Wegovy, Zepbound, diet pills, and long-term weight maintenance.

Medical weight loss options in NYC

Medical weight loss is not one treatment. It is a menu of evidence-based tools selected for the individual patient.

Treatment option Examples Best suited for W8MD role
Nutrition and lifestyle Protein-first meals, low-glycemic eating, meal timing, hydration, activity All patients Build a sustainable plan that fits culture, schedule, budget, and appetite pattern
Meal replacements Protein shakes, structured meal plans, very low-calorie plans when appropriate Patients needing structure or rapid early control Monitor safety, protein intake, hydration, and transition to maintenance
Traditional diet pills Phentermine, Topiramate, Qsymia, Contrave, Orlistat Patients who cannot access or tolerate GLP-1 medications or need combination strategies Choose based on blood pressure, mood, cravings, constipation, medication interactions, and goals
GLP-1 injections Wegovy, Ozempic, Saxenda, semaglutide-based options Appetite, food noise, weight maintenance, selected metabolic risk Evaluate eligibility, dose escalation, side effects, injection training, and prior authorization
Dual GIP/GLP-1 injections Zepbound, Mounjaro Patients needing substantial weight loss or diabetes-focused metabolic benefit Compare tirzepatide with semaglutide and traditional medications
Oral GLP-1 pills Wegovy pill, Rybelsus, Foundayo Patients who prefer pills or cannot tolerate injections Explain dosing differences, indications, insurance, and expected results
Sleep medicine Sleep apnea screening, home sleep study, CPAP, APAP Snoring, fatigue, daytime sleepiness, resistant weight regain Identify and treat sleep apnea that worsens appetite, fatigue, insulin resistance, and weight regain
Maintenance care Continued medication, lower-dose strategies, nutrition, resistance training, relapse prevention Patients who have lost weight or are plateauing Prevent regain and build long-term chronic weight management

FDA-approved long-term anti-obesity medications

The National Institute of Diabetes and Digestive and Kidney Diseases lists FDA-approved prescription drugs for chronic weight management, including orlistat, phentermine-topiramate, naltrexone-bupropion, liraglutide, semaglutide, and tirzepatide.<ref name="NIDDKObesityMeds">Prescription Medications to Treat Overweight and Obesity(link). National Institute of Diabetes and Digestive and Kidney Diseases.</ref> In 2026, the FDA also approved Foundayo or orforglipron tablets for long-term weight reduction in adults with obesity or adults with overweight and at least one weight-related comorbid condition.<ref name="FDAFoundayoApproval">FDA Approves First New Molecular Entity Under National Priority Voucher Program(link). U.S. Food and Drug Administration.2026-04-01.</ref><ref name="FoundayoLabel">Foundayo prescribing information(link). U.S. Food and Drug Administration.2026-04.</ref>

Medication Brand name Type Route Main role in medical weight loss
Orlistat Xenical, Alli Lipase inhibitor Oral Reduces absorption of dietary fat
Phentermine / Topiramate Qsymia Appetite and craving medication combination Oral Helps reduce appetite and support weight loss in selected patients
Naltrexone / Bupropion Contrave Craving and reward-pathway medication combination Oral Helps reduce cravings and appetite in selected patients
Liraglutide Saxenda GLP-1 receptor agonist Daily injection GLP-1 weight-loss injection
Semaglutide Wegovy GLP-1 receptor agonist Weekly injection or oral tablet depending on product Appetite, satiety, food noise, weight loss, maintenance
Tirzepatide Zepbound Dual GIP and GLP-1 receptor agonist Weekly injection Strong weight-loss option through dual incretin activity
Orforglipron Foundayo Oral GLP-1 receptor agonist Oral tablet Once-daily oral GLP-1 option for chronic weight management
Setmelanotide Imcivree Melanocortin 4 receptor agonist Injection Rare genetic obesity syndromes; not routine general obesity treatment

Diet pills for medical weight loss

Diet pills can still play an important role in medical weight loss, especially when GLP-1 medications are not covered, not tolerated, unavailable, or not preferred.

Phentermine

Phentermine is an appetite suppressant used for selected patients. It may help reduce hunger, but it must be used carefully in patients with high blood pressure, heart disease, anxiety, insomnia, stimulant sensitivity, or certain medication interactions.

W8MD may consider phentermine when:

  • Appetite is a major issue
  • Blood pressure is controlled
  • There is no major contraindication
  • A short-term or bridge strategy is needed
  • GLP-1 medications are not accessible
  • The patient understands monitoring requirements

Topiramate

Topiramate may help selected patients with cravings, binge-type eating patterns, night eating, migraines, or appetite control. It can cause cognitive slowing, tingling, mood effects, kidney-stone risk, and pregnancy-related safety concerns.

W8MD may consider topiramate as part of a personalized plan when cravings, food noise, or night eating are major issues.

Qsymia

Qsymia combines phentermine and topiramate extended release. It is FDA-approved for chronic weight management in selected patients.

Potential advantages include:

  • Appetite reduction
  • Craving reduction
  • Oral dosing
  • Non-GLP-1 option
  • May be useful when GLP-1 therapy is not covered

Important cautions include pregnancy risk, mood effects, cognitive side effects, heart-rate effects, and need for monitoring.

Contrave

Contrave combines naltrexone and bupropion. It is used for chronic weight management in selected adults and may be helpful when cravings, emotional eating, or reward-driven eating are major problems.

Contrave may be considered for patients with:

  • Cravings
  • Emotional eating
  • Reward-driven eating
  • Food noise
  • Need for oral non-GLP-1 therapy

Contrave may not be appropriate for patients with seizure disorder, uncontrolled hypertension, chronic opioid use, certain eating disorders, or specific medication interactions.

Orlistat

Orlistat reduces absorption of dietary fat. It is available as prescription Xenical and lower-dose over-the-counter Alli.

Orlistat may be considered when:

  • The patient prefers a non-appetite medication
  • GLP-1 therapy is not appropriate
  • Fat intake is moderate and manageable
  • The patient can follow vitamin supplementation guidance

Side effects may include oily stools, urgency, gas, and fat-soluble vitamin issues.

GLP-1 weight loss injections

GLP-1 weight loss injections are among the most requested medical weight loss options in NYC. They work by activating GLP-1 receptors involved in appetite, satiety, gastric emptying, insulin secretion, and glucagon regulation.

Examples include:

GLP-1 medications may help with:

  • Reduced hunger
  • Reduced food noise
  • Smaller portions
  • Improved satiety
  • Reduced cravings
  • Better glucose regulation
  • Weight loss and maintenance

Wegovy injection

Wegovy injection is a once-weekly semaglutide injection used for chronic weight management and selected cardiovascular-risk reduction indications. Wegovy is injected under the skin in the abdomen, thigh, or upper arm, with site rotation.

Wegovy may be appropriate for selected patients with obesity or overweight with weight-related conditions, depending on medical history, contraindications, coverage, and availability.

Wegovy pill

Wegovy pill is an oral semaglutide weight-management option for selected adults. Unlike injections, it is taken by mouth but requires strict timing.

Wegovy pill may be useful for patients who:

  • Prefer pills over injections
  • Can follow strict empty-stomach dosing instructions
  • Need semaglutide for chronic weight management
  • Want an alternative to weekly injections

Patients should not confuse Wegovy pill with Rybelsus, which is an oral semaglutide product for type 2 diabetes.

Wegovy HD

Wegovy HD is a higher-dose semaglutide injection option approved in 2026 for selected adults needing additional weight reduction and long-term maintenance. The FDA stated that the new higher dose provides another therapeutic option for selected adult patients with obesity or overweight with at least one weight-related condition.<ref name="FDAWegovyHD">FDA Approves Fourth Product Under National Priority Voucher Program: Higher-Dose Semaglutide(link). U.S. Food and Drug Administration.2026-03-19.</ref>

W8MD can help determine whether a patient is better suited for standard Wegovy, Wegovy HD, Wegovy pill, Zepbound, Foundayo, or another medication strategy.

Ozempic

Ozempic contains semaglutide and is used for type 2 diabetes and selected cardiometabolic indications. Patients often search for Ozempic for weight loss because Ozempic can reduce appetite and body weight, but Wegovy is the semaglutide brand used for weight management.

W8MD can explain the difference between Ozempic, Wegovy, Wegovy pill, Wegovy HD, Rybelsus, and affordable semaglutide-based options.

Rybelsus

Rybelsus is oral semaglutide used for adults with type 2 diabetes. It is not the same as Wegovy pill. Rybelsus has strict empty-stomach dosing instructions and is mainly a diabetes medication, although semaglutide may produce weight loss in some patients.

Saxenda

Saxenda is liraglutide, a daily GLP-1 receptor agonist injection for chronic weight management. It is older than Wegovy and Zepbound and requires daily injections.

Saxenda may still be considered in selected patients based on coverage, prior response, tolerability, age, availability, and clinical goals.

Tirzepatide and Zepbound

Zepbound is tirzepatide, a once-weekly dual GIP and GLP-1 receptor agonist used for chronic weight management and selected adults with obesity and moderate-to-severe obstructive sleep apnea. Mounjaro is the tirzepatide brand used for type 2 diabetes.

Tirzepatide may help through:

  • Dual GIP and GLP-1 receptor activity
  • Reduced appetite
  • Reduced food noise
  • Improved satiety
  • Reduced calorie intake
  • Improved glycemic control
  • Substantial weight loss in clinical trials

W8MD can help patients compare Zepbound with Wegovy, Wegovy HD, Wegovy pill, Foundayo, Ozempic, and other options.

Foundayo

Foundayo is the brand name for orforglipron, an oral GLP-1 receptor agonist tablet approved by the FDA in 2026 for use with a reduced-calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in adults with obesity, or adults with overweight in the presence of at least one weight-related comorbid condition.<ref name="FDAFoundayoApproval" /><ref name="FoundayoLabel" />

Foundayo may appeal to patients who want an oral GLP-1 option without injections. According to the FDA label, Foundayo should not be used with other GLP-1 receptor agonist medicines.<ref name="FoundayoLabel" />

Potential advantages include:

  • Oral GLP-1 option
  • No injection
  • Chronic weight-management indication
  • Useful for some patients who prefer pills
  • Alternative to injectable GLP-1 medications when appropriate

Important cautions include boxed thyroid C-cell tumor warning, pancreatitis risk, severe gastrointestinal reactions, acute kidney injury due to volume depletion, hypoglycemia risk with certain diabetes medications, hypersensitivity reactions, gallbladder disease, heart-rate increase, mood-related warnings, drug-interaction considerations, and pregnancy considerations.<ref name="FoundayoLabel" />

Meal replacements and very low-calorie diets

W8MD may use structured nutrition, protein shakes, or meal replacements when appropriate. These can help patients who need simplicity, portion control, or an early structured phase.

Meal replacement strategies may help with:

  • Portion control
  • Protein intake
  • Lower calorie intake
  • Reduced decision fatigue
  • Improved adherence
  • Transition planning
  • Maintenance structure

Very low-calorie diets should only be used with medical supervision, especially in patients with diabetes, kidney disease, gallbladder disease, eating disorder history, pregnancy, or complex medication regimens.

Nutrition and protein planning

Medical weight loss should protect muscle, not just reduce scale weight. W8MD emphasizes:

  • Protein-first meals
  • Protein shake support when appropriate
  • Meal replacements
  • Hydration
  • Fiber as tolerated
  • Lower-glycemic nutrition
  • Avoiding sugary drinks
  • Avoiding excessive alcohol
  • Smaller portions
  • Eating slowly
  • Avoiding greasy meals when using GLP-1 medications

Resistance training and muscle preservation

Weight loss can include muscle loss if patients eat too little protein or avoid strength training. W8MD encourages muscle preservation through:

  • Adequate protein
  • Resistance training
  • Walking
  • Strength exercises
  • Sleep quality
  • Avoiding crash diets
  • Hydration
  • Follow-up monitoring

Sleep apnea and medical weight loss

Obstructive sleep apnea is common in patients with obesity and can worsen fatigue, hunger, cravings, insulin resistance, blood pressure, and weight regain.

W8MD can help with:

Patients with snoring, daytime sleepiness, morning headaches, high blood pressure, large neck size, or persistent fatigue may benefit from sleep evaluation.

Emerging weight loss medications

Obesity medicine is changing rapidly. Several emerging or investigational medications may become important in future treatment.

Medication Mechanism Status Why it matters
Retatrutide Triple GIP, GLP-1, and glucagon receptor agonist Investigational, not FDA-approved as of this writing Lilly reported phase 3 obesity data with substantial weight loss; regulatory status may change
CagriSema Cagrilintide amylin analog plus semaglutide GLP-1 receptor agonist Submitted to FDA for weight management in December 2025, according to Novo Nordisk Combination strategy targeting appetite through GLP-1 and amylin pathways
Amycretin GLP-1 and amylin pathway therapy Investigational Oral and injectable forms have been studied; phase 3 development has been reported
MariTide GLP-1 receptor agonist plus GIP receptor antagonist strategy Investigational Studied as a longer-acting obesity therapy, including once-monthly dosing concepts
Next-generation oral GLP-1 medications Oral GLP-1 receptor agonism Some approved, others investigational May expand access for patients who prefer tablets over injections

Lilly reported that retatrutide 12 mg produced an average 28.3% weight loss over 80 weeks in a phase 3 obesity trial, but retatrutide remains investigational until approved by regulators.<ref name="RetatrutideLilly2026">Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal phase 3 obesity trial(link). Eli Lilly and Company.2026-05-21.</ref>

Novo Nordisk reported that CagriSema for weight management was submitted to the FDA in December 2025 based on REDEFINE pivotal trials.<ref name="CagriSemaNovo2026">Novo Nordisk company announcement on CagriSema regulatory pathway(link). Novo Nordisk.2026-02-02.</ref>

How W8MD chooses the best medication

W8MD personalized medication matching

Metabolic profile
W8MD reviews weight, BMI, waist circumference, insulin resistance, A1c, diabetes, blood pressure, cholesterol, and fatty liver risk.

Appetite and food noise
Some patients need GLP-1 or GIP/GLP-1 therapy, while others may benefit from Contrave, topiramate, phentermine, or combination strategies.

Pill versus injection preference
W8MD can compare Wegovy pill, Foundayo, Rybelsus, diet pills, Wegovy injections, Zepbound, and other options.

Coverage and affordability
W8MD can help with prior authorization when coverage is available and offers affordable GLP-1 options when medically appropriate.

How W8MD can help

W8MD can help eligible patients with:

W8MD affordable GLP-1 program

Affordable medical weight loss in NYC

W8MD helps eligible patients access physician-supervised medical weight loss when medically appropriate.

  • Semaglutide-based options starting as low as $29.99 per week and up with insurance for qualifying visits.
  • Self-pay semaglutide-based options starting from $59.99 per week and up when available and medically appropriate.
  • Tirzepatide-based options starting as low as $45.00 per week and up with insurance for qualifying visits.
  • Self-pay tirzepatide-based options starting from $69.99 per week and up when available and medically appropriate.
  • Most insurances accepted for qualifying medical visits.
  • W8MD can help with prior authorization for brand-name medications when coverage is available.
  • Pricing, insurance coverage, medication access, pharmacy availability, state rules, and eligibility vary by patient, location, and medical evaluation.

W8MD patient testimonials and success story themes

W8MD weight loss success themes

W8MD has helped thousands of patients work toward healthier weight, better metabolism, improved sleep, and long-term weight maintenance. Individual results vary, but patient testimonials and success stories often highlight several recurring themes:

“Finally understood”
Patients often appreciate that W8MD treats obesity as a medical condition, not a personal failure.
“Less food noise”
Many patients report better appetite control, fewer cravings, and smaller portions on appropriate treatment.
“More energy”
Sleep apnea screening, protein planning, and weight loss can improve fatigue and daily functioning in many patients.
“Affordable start”
Competitive GLP-1 pricing helps many patients begin physician-supervised care instead of delaying treatment.

These are testimonial themes and not a guarantee of results. Outcomes depend on medical history, medication choice, dose, nutrition, activity, sleep, side effects, medication access, insurance coverage, and follow-up.

Insurance prior authorization

Many brand-name weight-loss medications require insurance prior authorization. W8MD can help when coverage is available by documenting:

  • Current BMI
  • Starting weight and current weight
  • Weight-related medical conditions
  • Prior weight-loss attempts
  • Prior medication history
  • Side-effect history
  • Medical necessity
  • Type 2 diabetes status when relevant
  • Cardiovascular disease history when relevant
  • Sleep apnea diagnosis when relevant
  • Dose history and response
  • Follow-up visit notes

Approval is not guaranteed. Insurance decisions depend on plan rules, exclusions, diagnosis, benefit design, pharmacy benefit policies, step therapy, and medication availability.

Avoid unsafe online weight loss drugs

Patients should avoid unapproved online “research” peptides, counterfeit GLP-1 products, and medications marketed without legitimate medical supervision. The FDA has warned about concerns with unapproved GLP-1 drugs used for weight loss, including compounded semaglutide and tirzepatide products with safety, dosing, labeling, and quality concerns.<ref name="FDAUnapprovedGLP1">FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss(link). U.S. Food and Drug Administration.2026-06-15.</ref>

Safe medical weight loss requires:

  • A qualified prescriber
  • Correct diagnosis
  • Correct medication and dose
  • Clear pharmacy source
  • Side-effect monitoring
  • Nutrition support
  • Sleep evaluation when needed
  • Long-term maintenance planning

SEO: medical weight loss NYC near me

Patients searching for medical weight loss NYC, medical weight loss near me NYC, GLP-1 weight loss injections NYC, affordable semaglutide injections NYC, Wegovy doctor Brooklyn, Wegovy pill NYC, Foundayo doctor NYC, Contrave doctor NYC, diet pills NYC, Zepbound doctor New York City, Ozempic weight loss New Jersey, or medical weight loss clinic near me often need a physician-supervised program that offers multiple options rather than a one-size-fits-all prescription.

W8MD serves patients in and around:

Frequently asked questions

What is medical weight loss NYC?

Medical weight loss NYC is physician-supervised treatment for obesity, overweight, weight regain, food noise, insulin resistance, and related conditions for patients in New York City and nearby areas.

What medical weight loss options does W8MD offer?

W8MD offers nutrition support, meal replacements, traditional diet pills, GLP-1 weight loss injections, Wegovy, Wegovy pill, Wegovy HD, Ozempic education, Rybelsus education, Zepbound, Mounjaro education, Foundayo education, Contrave, Qsymia, phentermine, topiramate, orlistat, Saxenda, sleep apnea screening, and maintenance care when medically appropriate.

Does W8MD offer GLP-1 injections in NYC?

Yes. W8MD offers GLP-1 weight loss injection options, including semaglutide-based and tirzepatide-based programs when medically appropriate and available.

How much do GLP-1 shots cost at W8MD?

Semaglutide-based options may start as low as $29.99 per week and up with insurance for qualifying visits, or $59.99 per week and up self-pay. Tirzepatide-based options may start as low as $45.00 per week and up with insurance for qualifying visits, or $69.99 per week and up self-pay. Pricing and eligibility vary.

Does W8MD prescribe diet pills?

W8MD may prescribe or discuss diet pills such as phentermine, topiramate, Qsymia, Contrave, or orlistat when medically appropriate. Medication choice depends on blood pressure, heart history, mood history, pregnancy status, medication interactions, cravings, appetite pattern, and side-effect risk.

What is Foundayo?

Foundayo is orforglipron, an oral GLP-1 receptor agonist approved in 2026 for chronic weight management in adults with obesity or overweight with at least one weight-related comorbid condition, used with reduced-calorie diet and increased physical activity.<ref name="FDAFoundayoApproval" /><ref name="FoundayoLabel" />

Is Wegovy pill the same as Rybelsus?

No. Both involve oral semaglutide products, but Wegovy pill is a weight-management product and Rybelsus is a type 2 diabetes medication. Dosing, indication, and insurance criteria differ.

Can W8MD help choose between Wegovy, Zepbound, Foundayo, and Contrave?

Yes. W8MD can compare medication options based on weight goal, diabetes status, insulin resistance, sleep apnea, food noise, cravings, blood pressure, mood history, side effects, injection versus pill preference, insurance coverage, and cost.

Does W8MD help with sleep apnea and weight loss?

Yes. W8MD combines medical weight loss and sleep medicine. Patients with snoring, fatigue, daytime sleepiness, or resistant weight regain may benefit from sleep apnea screening and home sleep study testing.

Can W8MD help with insurance prior authorization?

Yes. When coverage is available and criteria are met, W8MD can help document BMI, comorbidities, medication history, treatment response, and medical necessity. Approval depends on the insurance plan.

Book a medical weight loss NYC consultation

W8MD Weight Loss Sleep and MedSpa team

Request an appointment with W8MD Brooklyn / NYC

W8MD offers physician-supervised medical weight loss NYC, obesity medicine, GLP-1 weight loss injections, affordable semaglutide injections, Wegovy injection, Wegovy pill, Wegovy HD, Zepbound for weight loss, Foundayo, Contrave, diet pills, insurance prior authorization support when coverage is available, nutrition support, sleep medicine, and long-term maintenance care.

Brooklyn / NYC Office

Address: 2632 E. 21st Street, Suite L3, Brooklyn, NY 11235

Phone: 718-946-5500

For patients searching for medical weight loss NYC, medical weight loss Brooklyn, GLP-1 shots NYC, Wegovy pill NYC, Foundayo doctor NYC, Contrave doctor NYC, or affordable semaglutide injections New York City.

Book Brooklyn / NYC Appointment

Important: Please do not submit sensitive medical information, Social Security numbers, insurance ID numbers, or urgent medical concerns through online appointment request forms. If this is a medical emergency, call 911.

Related W8MD pages

Relevant WikiMD links

External links

Core topics
GLP-1 and incretin therapy
Medication options
Appetite, nutrition, and sleep



Weight loss and medical weight loss

Main topics: Weight loss · Weight management · Medical weight loss · Obesity · Overweight · Body mass index · Waist circumference · Goal weight · Weight loss maintenance · Weight regain

W8MD topics: W8MD Weight Loss, Sleep and Medspa · W8MD diet · W8MD's weight loss diet · W8MD weight loss doctors · W8MD locations · Weight loss doctor · Weight loss NYC · Philadelphia weight loss · New Jersey weight loss · Pennsylvania weight loss

Medical weight loss services: Weight loss program · Weight loss programs · Weight loss coaching · Weight loss support · Weight loss support group · Weight loss journey · Weight loss transformation plan · Weight loss success stories · Weight loss reviews · Weight loss FAQ

Anti-obesity medications: Anti-obesity drugs · Weight loss medications · Weight loss injections · GLP-1 receptor agonist · Semaglutide · Tirzepatide · Wegovy · Zepbound · Mounjaro · Ozempic · Saxenda · Victoza · Trulicity

Traditional weight loss medications: Phentermine · Phendimetrazine · Diethylpropion · Qsymia · Phentermine/topiramate · Contrave · Naltrexone/bupropion · Orlistat · Plenity · Setmelanotide

Diet and nutrition: Weight loss diet · Healthy diet · Nutritious diet · Calorie deficit · Calorie · Portion control · Portion size · Meal plans · Meal replacement · Meal replacements · Protein shakes · Protein-rich foods

Low-carb and keto: Ketogenic diet · Keto diet · Low-carbohydrate diet · Low-carb diet · Very low-carbohydrate diet · Very low-calorie diet · VLCD diet · Protein-sparing modified fast · Keto foods · Low-carb recipes

Popular diet patterns: Mediterranean diet · DASH diet · High-protein diet · Low glycemic index diet · Intermittent fasting · Time-restricted feeding diet · Plant-based diet · Vegan weight loss · Paleo diet · South beach diet · Atkins diet

Exercise and activity: Exercise · Physical activity · Physical exercise · Aerobic exercise · Strength training · Strength training for weight loss · Walking · Swimming · Cycling · Yoga · Sedentary lifestyle

Metabolic health: Type 2 diabetes · Prediabetes · Insulin resistance · Metabolic syndrome · PCOS · Polycystic ovary syndrome · Fatty liver · Non-alcoholic fatty liver disease (NAFLD) · Osteoarthritis-weight-loss · Skin tags

Sleep and weight: Sleep apnea · Obstructive sleep apnea · Obesity hypoventilation syndrome · Sleep medicine · Sleep disorders · Sleep doctor NYC · Sleep center Brooklyn · Snoring · Insomnia · Zolpidem

Women and weight loss: Women-weight-loss · Women-lose-weight · Postpartum weight loss · Pregnancy-weight-gain · Perimenopausal-weight-gain · Post-menopausal-weight-gain · PCOS · Polycystic ovary syndrome

Weight loss articles and FAQs: Weight loss articles · The Basics of Weight Loss · Understanding Overweight and Obesity · Proven Weight Loss Options · Strategy for weight loss · Lose weight effectively · All-encompassing weight control · Motivation and Inspiration

Food and nutrition questions: What are some healthy foods? · What are some high protein foods? · What are some low-carb foods? · What are some low-carb vegetables? · What are some keto snacks? · What are some keto recipes? · What are some low-calorie meals?

Related measurements: Weight · Normal weight · Overweight · Obese · Obesity · Body mass index · Waist circumference · Waist-to-hip ratio (WHR) · Visceral fat · Body composition

Retrieved from "https://w8md.com/w/index.php?title=Medical_weight_loss_nyc&oldid=6566"